CCR2 and rheumatoid arthritis: Additionally, studies have demonstrated that targeting these chemokine receptors can reduce joint inflammation and damage, for example, inhibition of CCR2 has also been shown to reduce joint inflammation in animal models of RA and in human clinical trials.